Literature DB >> 19376689

Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent.

Christian Celia1, Elena Trapasso, Donato Cosco, Donatella Paolino, Massimo Fresta.   

Abstract

The stability of vesicular drug carriers containing linoleic acid, as a model of bilayer fluidizing agent, was evaluated using a Turbiscan optical analyzer, an innovative analytical instrument able to determine the long-time stability of colloidal systems. Ethosomes and ultradeformable liposomes were prepared using Phospholipon 100G as the lecithin component, while ethanol and sodium cholate were used for the specific preparation of ethosomes and ultradeformable liposomes, respectively. The advantages of the Turbiscan optical analyzer are: (i) its ability to measure reversible (creaming and sedimentation) and irreversible (coalescence and segregation) destabilization phenomena directly in the sample without any dilution and (ii) to detect these phenomena much earlier and easier than other apparatuses. Turbiscan data showed that both colloidal vesicles demonstrate a good stability during the 3h of the experiment. No modification of Turbiscan backscattering profiles of colloidal suspensions occurred when different amounts of linoleic acid were used to prepare ethosomes and ultradeformable liposomes. No coalescence, sedimentation, flocculation or clarification occurred. The results were very encouraging and confirmed the fact that the Turbiscan optical analyzer can be used to study the stability of colloidal formulations even in the presence of deformable agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19376689     DOI: 10.1016/j.colsurfb.2009.03.007

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  36 in total

1.  Formulation of oil-in-water emulsions for pesticide applications: impact of surfactant type and concentration on physical stability.

Authors:  Jianguo Feng; Qicheng Chen; Xuemin Wu; Seid Mahdi Jafari; David Julian McClements
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-22       Impact factor: 4.223

2.  Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature.

Authors:  Lívia Palmerston Mendes; Marilisa Pedroso Nogueira Gaeti; Paulo Henrique Marcelino de Ávila; Marcelo de Sousa Vieira; Bruna Dos Santos Rodrigues; Renato Ivan de Ávila Marcelino; Lílian Cristina Rosa Dos Santos; Marize Campos Valadares; Eliana Martins Lima
Journal:  Pharm Res       Date:  2013-10-30       Impact factor: 4.200

3.  Sustained zero-order release of intact ultra-stable drug-loaded liposomes from an implantable nanochannel delivery system.

Authors:  Christian Celia; Silvia Ferrati; Shyam Bansal; Anne L van de Ven; Barbara Ruozi; Erika Zabre; Sharath Hosali; Donatella Paolino; Maria Grazia Sarpietro; Daniel Fine; Massimo Fresta; Mauro Ferrari; Alessandro Grattoni
Journal:  Adv Healthc Mater       Date:  2013-07-23       Impact factor: 9.933

4.  Laronidase-functionalized multiple-wall lipid-core nanocapsules: promising formulation for a more effective treatment of mucopolysaccharidosis type I.

Authors:  Fabiana Quoos Mayer; Márcia Duarte Adorne; Eduardo André Bender; Talita Giacomet de Carvalho; Anna Cláudia Dilda; Ruy Carlos Ruver Beck; Sílvia Stanisçuaski Guterres; Roberto Giugliani; Ursula Matte; Adriana Raffin Pohlmann
Journal:  Pharm Res       Date:  2014-09-11       Impact factor: 4.200

5.  Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.

Authors:  Mingyuan Li; Zhiping Li; Yang Yang; Zhiyuan Wang; Zhenbo Yang; Bingsheng Li; Xiangyang Xie; Jinwen Song; Hui Zhang; Ying Li; Guangyu Gao; Jingyuan Yang; Xingguo Mei; Wei Gong
Journal:  Pharm Res       Date:  2016-04-13       Impact factor: 4.200

6.  Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer.

Authors:  Xianzhu Ke; Wen Lin; Xiaokang Li; Hailiang Wang; Xin Xiao; Zheng Guo
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.

Authors:  Yue Zhang; Meifang Zhai; Zhijiang Chen; Xiaoyang Han; Fanglin Yu; Zhiping Li; Xiangyang Xie; Cuiyan Han; Lian Yu; Yang Yang; Xingguo Mei
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  Improvement of Ferulic Acid Antioxidant Activity by Multiple Emulsions: In Vitro and In Vivo Evaluation.

Authors:  Antonia Mancuso; Maria Chiara Cristiano; Rosanthony Pandolfo; Manfredi Greco; Massimo Fresta; Donatella Paolino
Journal:  Nanomaterials (Basel)       Date:  2021-02-08       Impact factor: 5.076

9.  EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment.

Authors:  Maria Chiara Cristiano; Antonia Mancuso; Elena Giuliano; Donato Cosco; Donatella Paolino; Massimo Fresta
Journal:  J Funct Biomater       Date:  2021-05-16

10.  Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma.

Authors:  Mahmoud M A Elsayed; Tarek M Okda; Gamal M K Atwa; Gamal A Omran; Atef E Abd Elbaky; Abd El Hakim Ramadan
Journal:  Pharmaceutics       Date:  2021-05-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.